MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $87.21 million versus the consensus estimate of $89.09 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.